Results 101 to 110 of about 24,300 (246)

Postoperative Atrial Arrhythmias After Lung Transplantation: A Single Center Analysis of Risk Factors, Management, and Outcomes

open access: yesClinical Transplantation, Volume 40, Issue 2, February 2026.
ABSTRACT Background Postoperative atrial arrhythmia (POAA) is common after lung transplant, but data on its implications and management are limited. This study assessed POAA incidence and timing, its association with mortality and rehospitalizations, and outcomes related to postoperative beta‐blocker use.
Daniel M. Chen   +11 more
wiley   +1 more source

Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation

open access: yesAdvanced Science, Volume 13, Issue 1, 5 January 2026.
A dual‐targeting nanoparticle platform that selectively engages graft stromal cells via CD248 receptors while employing kidney‐ specific promoters (NPHS2) to drive localized IL‐ 2/TGF‐βexpression is developed. This approach achieves three therapeutic objectives:1) intragraft Treg polarization without systemic cytokine exposure;2) reduced dependence on ...
Tong Lu   +18 more
wiley   +1 more source

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantationResearch in context

open access: yesEBioMedicine, 2019
Background: Allograft failure is common in lung-transplant recipients and leads to poor outcomes including early death. No reliable clinical tools exist to identify patients at high risk for allograft failure.
Sean Agbor-Enoh   +27 more
doaj   +1 more source

Clinical significance of asymptomatic cytomegalovirus viremia in lung transplant recipients receiving universal antiviral prophylaxis [PDF]

open access: yes, 2015
Background: Cytomegalovirus (CMV) disease has been associated with the development of chronic lung allograft dysfunction (CLAD) after lung transplantation.
JAAMEI, N.
core  

A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring. [PDF]

open access: yes, 2019
A Common Rejection Module (CRM) consisting of 11 genes expressed in allograft biopsies was previously reported to serve as a biomarker for acute rejection (AR), correlate with the extent of graft injury, and predict future allograft damage.
Bestard, Oriol   +8 more
core   +2 more sources

Outcomes of lung transplantation for scleroderma versus other indications: Insigts from a single center

open access: yesJHLT Open
Background: Scleroderma is an autoimmune disease affecting the skin and internal organs, with pulmonary disease being the leading cause of mortality.
Masashi Furukawa, MD PhD   +4 more
doaj   +1 more source

Usefulness of gene expression profiling of bronchoalveolar lavage cells in acute lung allograft rejection. [PDF]

open access: yes, 2019
BackgroundChronic lung allograft dysfunction (CLAD) is the main limitation to long-term survival after lung transplantation. Because effective therapies are lacking, early identification and mitigation of risk factors is a pragmatic approach to improve ...
Belperio, John A   +13 more
core   +1 more source

Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study

open access: yesTransplantation Direct
Background. A prior single-center, retrospective cohort study identified baseline lung allograft dysfunction (BLAD) as a risk factor for death in bilateral lung transplant recipients.
Michael B. Keller, MD   +14 more
doaj   +1 more source

Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults

open access: yesSwiss Medical Weekly, 2017
BACKGROUND Extracorporeal photopheresis (ECP) has been reported to be safe and the ultimate treatment option in lung transplant recipients with chronic lung allograft dysfunction (CLAD), the main overall cause of mortality in lung transplant ...
Cécile Robinson   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy